Department of Pediatric Surgery and Urology, Robert-Debré University Hospital, APHP, Université Paris Cité, Paris, France; Reference Expert Center for Rare Diseases « Maladies Endocriniennes de la Croissance et du Développement » (CRESCENDO), Paris, France; Pediatric Surgery Unit, Assiut University Children Hospital, Assiut, Egypt.
Department of Pediatric Surgery and Urology, Robert-Debré University Hospital, APHP, Université Paris Cité, Paris, France; Reference Expert Center for Rare Diseases « Maladies Endocriniennes de la Croissance et du Développement » (CRESCENDO), Paris, France.
J Pediatr Surg. 2024 Sep;59(9):1851-1858. doi: 10.1016/j.jpedsurg.2024.05.009. Epub 2024 May 28.
Congenital adrenal hyperplasia (CAH) is the most common cause of genital atypia in females. A dedicated multidisciplinary team (MDT) should be included for an optimal management. Here, we aimed to review our surgical experience and to assess long-term urinary, gynecological and endocrine outcomes after primary genitoplasty in this specific cohort.
Patients born with CAH and who underwent feminizing genitoplasty in our institution were retrospectively identified (2001-2021). We analyzed patients' characteristics, intraoperative details, and postoperative urinary, gynecological, and endocrine outcomes.
Forty patients were included and followed-up for a median (IQR) time of 7 (1-19) years. Thirty-eight (95%) had 21-hydroxylase deficiency. After multidisciplinary decision and written consent from patient and/or family, a single-stage reconstructive surgery was performed at a median age of 10 (3-165) months. Median length of hospital stay was 5 (1-7) days. Procedures were: PUM (N = 35 (87.5%)), TUM (N = 3 (7.5%)), urogenital mobilization was unnecessary in 2 (5%). Reduction clitoroplasty was done in 33 (82.5%) patients. Only 3 (7.5%) experienced significant Clavien-Dindo complications requiring additional surgery during the follow-up period. Recurrent urinary tract infections (UTI) occurred in 6 (15%), one required ureteric reimplantation for symptomatic high-grade vesicoureteric reflux. All patients over 3 years were toilet-trained without incontinence. Severe vaginal stenosis occurred in 1 (2.5%) patient. In patients who achieved puberty, 6/9 had vaginal calibration at a median age of 17.3 (16-21) years without detected stenosis. One (2.5%) had major hypertrophy of the right labia minora requiring labiaplasty. Nine (22.5%) reached puberty. Two (5%) patients developed acne/hirsutism. Short stature was noted in 11 (27.5%) and obesity in 18 (45%).
Based on our contemporary series, genitourinary reconstructive surgery for female patients born with CAH is technically feasible and safe with a low complication rate. A regular follow-up with a MDT to assess long-term complications is necessary, and it is vital to inform patients and families about the different management options with all the risks and benefits of surgery.
original research, clinical research.
Level 3 retrospective study.
先天性肾上腺皮质增生症(CAH)是女性外生殖器畸形最常见的原因。应该有一个专门的多学科团队(MDT)来进行最佳的管理。在这里,我们旨在回顾我们的手术经验,并评估在这一特定队列中,女性患者在接受初次生殖器整形手术后的长期泌尿、妇科和内分泌结果。
我们回顾性地确定了在我们机构接受 CAH 治疗并接受女性生殖器整形术的患者(2001-2021 年)。我们分析了患者的特征、手术细节以及术后泌尿、妇科和内分泌结果。
共纳入 40 例患者,中位(IQR)随访时间为 7(1-19)年。38 例(95%)患有 21-羟化酶缺乏症。经过多学科决策并获得患者和/或家属的书面同意后,在中位年龄为 10(3-165)个月时进行了单阶段重建手术。中位住院时间为 5(1-7)天。手术方式包括:阴蒂成形术(PUM)(n=35(87.5%)),阴唇成形术(TUM)(n=3(7.5%)),2 例(5%)无需进行泌尿生殖器官动员。33 例(82.5%)患者行阴蒂缩小术。在随访期间,仅有 3 例(7.5%)发生了需要额外手术的严重 Clavien-Dindo 并发症。6 例(15%)患者出现复发性尿路感染(UTI),其中 1 例因症状性高级别输尿管反流而需要进行输尿管再植入术。所有 3 岁以上的患者均能进行如厕训练且无尿失禁。1 例(2.5%)患者发生严重阴道狭窄。在已达到青春期的患者中,6/9 例在中位年龄 17.3(16-21)岁时进行了阴道校准,未发现狭窄。1 例(2.5%)患者右侧小阴唇过度肥大,需要行小阴唇整形术。9 例(22.5%)患者达到青春期。2 例(5%)患者出现痤疮/多毛症。11 例(27.5%)患者身材矮小,18 例(45%)患者肥胖。
基于我们的当代系列研究,出生时患有 CAH 的女性患者的泌尿生殖系统重建手术在技术上是可行且安全的,并发症发生率低。需要定期与 MDT 进行随访以评估长期并发症,并且告知患者和家属不同的治疗选择及其手术的所有风险和益处至关重要。
原始研究,临床研究。
3 级回顾性研究。